Taiwanese drug maker Adimmune Corp. on Thursday said it has started the first phase of human trials for its experimental COVID-19 vaccine this week, with Phase 2 likely to follow in November if everything goes well.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
-
Business
U.S. dollar up in Taipei trading
03/27/2026 10:45 AM -
Society
Taiwan headline news
03/27/2026 10:15 AM -
Business
Taiwan shares open lower
03/27/2026 09:08 AM -
Politics
Ko Wen-je vows to 'not surrender,' denies guilty verdict
03/26/2026 10:49 PM -
Society
2,642 flu vaccine doses recalled over discoloration
03/26/2026 10:16 PM